The American Society of Clinical Oncology (ASCO) is the world's leading professional organization representing physicians who treat people with cancer. ASCO's members set the standard for patient care worldwide, and lead the fight for more effective cancer treatments, increased funding for clinical and translational research, and, ultimately, cures for the many different cancers that strike millions of people around the world every year.
http://www.asco.org/ASCO/News/Cancer+News?&reuterview=asco_list_view&type=p - 01/08/09 11:35:07 - 08/06/08 01:21:07
Oral agent suitable for previously treated non-small-cell lung cancer
November 21, 2008
NEW YORK (Reuters Health) - New research indicates that gefitinib, an oral agent, is a suitable alternative to intravenous docetaxel for patients with previously treated non-small-cell lung cancer.
